GLP-1s, Specialty Spend, and a 9% Cost Surge: Why Employers Must Rethink Primary Care Now
The question isn’t whether costs will rise. It’s whether employers will continue managing around the margins — or address the root cause.
4 Prescription Drug Trends that are Top of Mind for One Abarca Exec
Abarca Health is paying attention to specialty drugs, AI in healthcare, the impact of obesity-related conditions, and increased government regulations.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
MedCity Pivot Podcast: A Conversation With Walgreens’ Head of Specialty Drugs
Tracey James, chief operating officer of Walgreens' specialty pharmacy business, talked about the retailer's vision of innovating in the specialty pharmacy world, as well as about affordability and access.
White Bagging Policies Endanger the Lives of Cancer Patients
Insurers and PBMs are increasingly implementing white-bagging policies, which require oncology practices to obtain physician-administered infusions and other medications from designated specialty pharmacies often owned by or affiliated with insurers and their PBMs.
What Will Value-Based Drug Pricing Look Like By 2030? Experts Share 4 Predictions
Panelists at a recent pharmacy conference were optimistic about the future of value-based drug contracting. For example, one said that healthcare will be close to establishing a value-based formulary by 2030, and another said that longitudinal patient tracking will become a more important part the drug pricing process.
Startup raises $6M to make it easier to fill specialty scripts
HelpAround raised $6 million in funding from IQVIA and Windham Ventures. The company’s software is designed to make it easier for patients to navigate specialty prescriptions.
presented by
New Webinar: The Payer AI Readiness Gap: Why Better Data Will Define the Next Era of Health Plan Performance
We'll explore why the next era of payer performance will depend on building a trusted data foundation that connects people, providers, and relationships across the enterprise.